Drug Shortage Report for MILRINONE LACTATE INJECTION

Last updated on 2022-06-18

Report ID 161808
Drug Identification Number 02244854
Brand name MILRINONE LACTATE INJECTION
Common or Proper name MILRINONE LACTATE
Company Name SANDOZ CANADA INCORPORATED
Market Status CANCELLED POST MARKET
Active Ingredient(s) MILRINONE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10ML 10LIVI
ATC code C01CE
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-06-03
Estimated end date Unknown
Actual end date 2022-06-17
Shortage status Resolved
Updated date 2022-06-18
Company comments Product discontinued
Health Canada comments
Tier 3 Status No
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2022-06-18 English Compare
v5 2022-06-17 French Compare
v4 2022-06-17 English Compare
v3 2022-06-04 English Compare
v2 2022-06-03 French Compare
v1 2022-06-03 English Compare

Showing 1 to 6 of 6